This MedLibrary.org supplementary page on Clinical trial protocol is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
A Clinical Trial Protocol is a document that describes the objective(s), design, methodology, statistical considerations, and organization of a clinical trial. The protocol usually also gives the background and reason the trial is being conducted, but these could be provided in other documents referenced in the protocol (such as an Investigator's Brochure).
The protocol contains a study plan on which the clinical trial is based. The plan is designed to safeguard the health of the participants(while limiting their financial liablity) as well as answer specific research questions. The protocol describes, among other things, what types of people may participate in the trial; the schedule of tests, procedures, medications, and dosages; and the length of the study. While in a clinical trial, study participants are seen regularly by the research staff (usually medical doctors and/or nurses) to monitor their health and to determine the safety and effectiveness of the treatment(s) they are receiving.
The format and content of clinical trial protocols sponsored by pharmaceutical, biotechnology or medical device companies in the United States, European Union, or Japan has been standardized: they are written to follow the Good clinical practice guidance issued by the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Regulatory authorities in Canada and Australia also follow the ICH guidance.
Clinical trial protocols for other clinical trials do not necessarily follow the standard format.
The existence of a clinical trial protocol allows researchers at multiple locations (in a multicenter trial) to perform the study in exactly the same way, so that their data can be combined as though they were all working together. The protocol also gives the study administrators (often a contract research organization) as well as the local researchers a common reference document for the researchers' duties and responsibilities during the trial.
References
- ICH Guideline for Good Clinical Practice: Consolidated Guidance
- ICH Guideline for Structure and Content of Clinical Study Reports
- United States National Institutes of Health Glossary of Clinical Trial Terms
See also
- Protocol (natural sciences)
- Treatment Guidelines from The Medical Letter
- Drug development
- Ethics Committee (European Union)
- Data Monitoring Committee
- Case Report Form
- Patient-reported outcome
- Guideline (medical)
- Clinical Data Interchange Standards Consortium
Regulatory Agencies Using ICH Guidelines for Clinical Trial Protocol
- Food and Drug Administration (FDA)
- European Medicines Agency (EMEA)
- Japanese Ministry of Health, Labour and Welfare (MHLW)
- Health Canada
- Australian Therapeutic Goods Administration (TGA)
Wikipedia content modification information:
- This page was last modified on 16 June 2008, at 19:44.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Clinical trial protocol".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.